Skip to main content
Menu
US

HTRF Human Phospho-IRF3 (Ser385/386) Detection Kit, 500 Assay Points

The phospho-IRF3 (Ser386) assay enables the cell-based detection of Ser386 phosphorylation on IRF3.

Click to copy promo code to clipboard.
March lab savings - buy on Revvity.com or Revvity punchout to SAVE 10% with promo code!
MARCH10
Sale ends 3/24. Terms and conditions apply.
Feature Specification
Application Cell Signaling
Sample Volume 16 µL

The phospho-IRF3 (Ser386) assay enables the cell-based detection of Ser386 phosphorylation on IRF3.

Click to copy promo code to clipboard.
March lab savings - buy on Revvity.com or Revvity punchout to SAVE 10% with promo code!
MARCH10
Sale ends 3/24. Terms and conditions apply.
Product Variants
Unit Size: 500 assay points
Part #:
6FRF3PEG
List Price
USD 2,271.53
Your online price:
Unit Size: 10,000 assay points
Part #:
6FRF3PEH
List Price
USD 13,214.42
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

The phospho-IRF3 cell based assay kit conveniently and accurately quantifies phosphorylated IRF3 at Ser386. In viral infected cells, phosphorylation of transcription factor IRF3 induces the production of antiviral and proinflammatory cytokines, a key element in the innate immunity system. This phospho-IRF3 assay can be used from basic research through to preclinical drug discovery phases and contains everything you need. It offers increased throughput compared to ELISA/WB.

Specifications

Application
Cell Signaling
Brand
HTRF
Detection Modality
HTRF
Lysis Buffer Compatibility
Lysis Buffer 2
Lysis Buffer 3
Molecular Modification
Phosphorylation
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Phosphoproteins
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Cardiovascular
Infectious Diseases
NASH/Fibrosis
Neuroscience
Oncology & Inflammation
Unit Size
500 assay points

Video gallery

How it works

Phospho-IRF3 (Ser386) assay principle

The phospho-IRF3 (Ser386) assay measures IRF3 when phosphorylated at Ser386. Contrary to Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer. The phospho-IRF3 (Ser386) assay uses 2 labeled antibodies: one with a donor fluorophore, the other one with an acceptor. The first antibody is selected for its specific binding to the phosphorylated motif on the protein, the second for its ability to recognize the protein independent of its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both labeled antibodies and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the proteins phosphorylation state under a no-wash assay format.

phospho-how-it-works-phospho-irf3-ser386-assay-principle
Phospho-IRF3 (Ser386) 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis then transferring lysates to a 384-well low volume detection plate before adding phospho-IRF3 (Ser386) HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

phospho-how-it-works-phospho-irf3-ser386-2-plate-assay-protocol
Phospho-IRF3 (Ser386) 1-plate assay protocol

Detection of Phosphorylated IRF3 (Ser386) with HTRF reagents can be performed in a single plate used for culturing, stimulation and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

phospho-how-it-works-phospho-irf3-ser386-1-plate-assay-protocol

 

Assay validation

Optimization of Calyculin incubation time

Calyculin, a potent serine/threonine protein phosphatase inhibitor, was used to induce phosphorylation of IRF3 in MCF7 cells. After treatment for various incubation times (45 minutes, 1 hour, 2 hours, or 3 hours) with 400 nM Calyculin, MCF7 cells were lysed with 50 µL of supplemented lysis buffer and incubated for 30 min at RT under gentle shaking. 16 µL of lysate were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF phospho-IRF3 detection reagents. The HTRF signal was recorded after an overnight incubation.

assay-validation-irf3-phospho-s386-1
IRF3 phosphorylation upon 2-3 cGAMP stimulation

125,000 MCF7 cells per well were pated in a 96-well pate in complete culture medium and incubated for 24h at 37°C, 5% CO2. 50 µg/mL of 2-3 cGAMP was added and then incubated for various incubation time at 37°C. After cell culture removal the cells were lysed with 50 µL of lysis buffer for 30 min at RT, 16 µL of lysate were then transferred into a 384-well sv white pate and 4 µL of the HTRF phospho-IRF3 detection reagents were added. The HTRF signal was recovered after over-night incubation.

assay-validation-irf3-phospho-s386
Phospho-IRF3 assay compared to western Blot in human MCF7 cells

Human MCF7 cells were cultured for 48 hours and then stimulated with 200nM calyculin for 2 hours lysing. Soluble fractions were collected via centrifugation and serial dilutions of the cell lysate were performed in the supplemented lysis buffer and 16 µL of each dilution were dispensed and analyzed side-by-side by Western-blot and by HTRF. By using HTRF phospho-IRF3 (Ser386) only 2,500 cells are sufficient for minimal signal detection while 10,000 cells are needed for a Western Blot signal. The HTRF phospho-IRF3 assay is at least 4-fold more sensitive than the Western-blot.

assay-validation-irf3-phospho-s386-3

 

Simplified pathway

IRF3 Simplified Pathway

IRF3 is a key transcriptional regulator of type I interferon (IFN-alpha and IFN-beta)-dependent immune responses. It plays a critical role in the innate immune response against DNA and RNA viruses. Found in an inactive form in the cytoplasm of uninfected cells, IRF3 becomes phosphorylated at Ser 386 by TBK1, following viral infection, double-stranded RNA (dsRNA), Toll-like receptor (TLR) and STING signaling pathways. This induces a conformational change, leading to its dimerization and nuclear localization where it can activate type I IFN gene expression.

phospho-pathway-irf3-6frf3peg-6frf3peh-6frf3pey

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Guide Icon
Guide
Benefit from an insight into the diversity of immune cells & signaling pathways

Get a useful overview of today’s immunity knowledge with this booklet

Immunity is a collection of complex processes involving...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Flyer Icon
Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies

Scroll Icon